Together with our London Regional Hub we are hosting a Showcase event on Data Led Prioritisation - managing wait lists through effective clinical prioritisation and service optimisation.
Since the beginning of the COVID-19 pandemic, NHS waiting lists for new appointments have grown from 4.2 to 7.4 million, caused by a perfect storm of increasing demand, staff shortages and reduced availability of inpatient beds.
The time that patients wait for an outpatient appointment have also increased significantly, and the challenge of meeting follow-up demand on existing patients with chronic conditions such as diabetes, reduces the capacity for services to accept new patient referrals.
In response to these mounting problems, NHS England have produced guidance that outlines a strategy to reduce wait times for elective care with a key goal being to prioritise vulnerable patients within waiting lists.
But how is this to be achieved under tight funding and resource constraints?
Join us for this interactive event showcasing an innovative joint project between GSTT and Factor 50, using data led prioritisation to reduce clinical risk and manage capacity in Diabetes Outpatients. This project is winner of the 2023 HSJ award for Driving Change Through Data & Analytics
This event is chaired by Dr Daghni Rajasingham.
Meet the panel;
Dr Daghni Rajasingam is a consultant obstetrician & Deputy Medical Director at Guy's and St Thomas' NHS Foundation Trust
Mark Hawkins, Founder & CEO of Factor 50
Dr Janaka Karalliedde is a Clinical Reader in Diabetes and Cardiovascular Disease in the School of Cardiovascular Medicine & Sciences at King's and Consultant Physician in Diabetes and Endocrinology and Internal Medicine at Guy’s and St Thomas Hospital London
Dr Daghni Rajasingam is a consultant obstetrician & Deputy Medical Director at Guy's and St Thomas' NHS Foundation Trust. Daghni is Chief Regional Obstetrician for the South East of England. She is also an Honorary Reader in Leadership & Healthcare Management and Senior Clinical Lead for the Centre for Innovation, Transformation & Improvement.
Mark Hawkins is Founder & CEO of Factor 50. Mark has 20 years experience in financial services. With Matt Denman, he founded HD Decisions in 2008, after 10 years at Capital One. HD is now owned by Experian and employs 100 people in Nottingham. He has an MBA from Stanford and an Engineering Degree from Cambridge.
Dr Janaka Karalliedde is a Clinical Reader in Diabetes and Cardiovascular Disease in the School of Cardiovascular Medicine & Sciences at King's and Consultant Physician in Diabetes and Endocrinology and Internal Medicine at Guy’s and St Thomas Hospital London. Dr Karalliedde has been awarded research grants from the UK Medical Research Council, Diabetes UK, European Foundation for the Study of Diabetes, International Diabetes Federation, NIHR and Industry for investigator led proof of concept clinical trials. His research is focussed on developing new therapies and treatment targets to reduce cardio-renal disease risk and complications in people with diabetes. In parallel, Dr Karalliedde leads research projects focussed on cardio-renal disease predictors and bio-markers and their potential for real world application to guide risk stratification of people at high risk of rapid progression of kidney disease. Dr Karalliedde runs specialist clinics for patients with diabetes related kidney and vascular complications at Guy’s and St Thomas’ Hospital London and has established community based multi-disciplinary diabetes clinics focussed on early identification of high risk persons and reducing cardiovascular and kidney complications of diabetes.
IHSCM Members can attain 1 High Performance Leadership Framework points for watching this event towards Innovation. ihm.org.uk/hpl-dashboard/